Manager/Senior Manager, Pharmacovigilance Operations jobs in United States
cer-icon
Apply on Employer Site
company-logo

Agenus · 8 hours ago

Manager/Senior Manager, Pharmacovigilance Operations

Agenus is a dedicated group of scientists, physicians, and businesspeople working to discover and develop therapies for cancer. The role involves supporting clinical-stage oncology programs through direct execution of pharmacovigilance activities, including case review, safety document authoring, and signal detection while collaborating with cross-functional teams.

BiotechnologyMedicalMedical DeviceTherapeutics
check
H1B Sponsor Likelynote
Hiring Manager
Jeniece Waite
linkedin

Responsibilities

Perform hands-on review of Individual Case Safety Reports (ICSRs), including assessment of seriousness, expectedness, and regulatory reporting requirements
Author and contribute directly to DSURs, Investigator Brochures (IBs), and other aggregate safety reports, including safety narratives and data interpretation
Conduct and support signal detection and safety trend analyses, including preparation of data listings and participation in safety review meetings
Work directly in the safety database (e.g., Argus/ARISg) to review, QC, and manage safety data
Support day-to-day pharmacovigilance operations, ensuring timely, accurate, and compliant safety reporting
Partner closely with safety vendors, performing quality review of deliverables and following up on queries and timelines
Support SAE reconciliation between clinical and safety databases
Contribute to the development and maintenance of SOPs, Safety Management Plans (SMPs), and work instructions
Collaborate with Medical Safety, Clinical Operations, Data Management, and Regulatory Affairs to ensure consistent and compliant safety data
Participate in safety review committees and study team meetings as an operational PV representative
Support inspection readiness activities, including documentation preparation and response support

Qualification

PharmacovigilanceICSR reviewSignal detectionSafety database (Argus)GCPGVPICH guidelinesOncology experienceClinical-stage programsAudit supportTeam collaborationIndependent work

Required

4–8 years of direct pharmacovigilance or drug safety experience, with a strong emphasis on hands-on execution
Demonstrated experience with: ICSR review and processing, DSUR and IB safety section writing, Signal detection or safety data trending
Working knowledge of GCP, GVP, and ICH guidelines
Experience using global safety databases (Argus, ARISg, or similar)
Ability to work independently in a lean, fast-moving biotech environment
Oncology or immuno-oncology experience
Prior experience supporting clinical-stage programs
Experience contributing to audits or inspections

Benefits

Medical, Dental & Vision Coverage – Competitive options for both US & UK employees
Flexible Spending Accounts – For healthcare and dependent care expenses (US)
Flexible Vacation Plan – We believe time away leads to better thinking and innovation.
Care.com Memberships – Support for family care (US)
Education Assistance Program – Invest in your learning and development (US)
401(k) Match
Employee Stock Purchase Plan
Employee Assistance Program (EAP) – Resources for mental health, well-being, and life support
Reward & Recognition Program – Celebrate contributions that move the mission forward

Company

Agenus

twittertwittertwitter
company-logo
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.

H1B Sponsorship

Agenus has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (4)
2024 (1)
2023 (4)
2022 (7)
2021 (4)
2020 (4)

Funding

Current Stage
Public Company
Total Funding
$382.14M
Key Investors
Zynext VenturesLigand Pharmaceuticals
2025-06-03Post Ipo Equity· $16M
2024-11-27Post Ipo Debt· $20M
2024-05-07Post Ipo Debt· $75M

Leadership Team

leader-logo
Robin Taylor
Chief Commercial Officer
linkedin
Company data provided by crunchbase